Subscribe To
Vir biotechnology (vir) down on influenza study failure
Vir Biotechnology (VIR) crashes after the phase II study evaluating VIR-2482 for preventing symptomatic influenza A illness fails to meet goals....
July 21, 2023, 1:42 pm
: turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range
Turnstone Biologics Corp. TSBX is headed for its public debut Friday, as the San Diego-based biotechnology company focused on treating tumors raised $...
July 21, 2023, 12:20 pm
Turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range
Turnstone Biologics Corp. TSBX, is headed for its public debut Friday, as the San Diego-based biotechnology company focused on treating tumors raised ...
July 21, 2023, 8:20 am
Turnstone biologics corp. announces pricing of upsized initial public offering
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotec...
July 21, 2023, 6:15 am
Cidara therapeutics provides update on status of ongoing cd388 influenza program
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics de...
July 20, 2023, 9:00 pm
: vir biotechnology’s stock slides 40% after it says mid-stage trial of a flu treatment failed to meet main goals
Vir Biotechnology Inc. VIR said Thursday a mid-stage trial of a treatment for symptomatic flu failed to meet its main goals, sending the stock down 40...
July 20, 2023, 5:59 pm
Champions oncology to announce fourth quarter and year-end financial results on monday, july 24, 2023
HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled ...
July 20, 2023, 4:00 pm
Vir biotech slumps to over 3-year low as flu prevention therapy fails trial
Vir Biotechnology's shares plunged 45% to a more than three-year low on Thursday after the company's experimental antibody therapy to prevent a type o...
July 20, 2023, 12:37 pm
Why shares of vir biotechnology are plunging thursday
Vir Biotechnology has seen declining revenue because sales of its one marketed product, Sotrovimab, are declining. A phase 2 trial for an influenza A ...
July 20, 2023, 11:31 am
Unicycive therapeutics to participate in the h.c. wainwright 2nd annual kidney conference
LOS ALTOS, Calif., July 20, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing t...
July 20, 2023, 11:03 am
Medpace: resilience during the down cycle
Medpace Holdings, a Clinical Research Organisation (CRO), has outperformed in the stock market with a return of 429% in the last five years compared t...
July 20, 2023, 9:00 am
Legend biotech shares gain on multiple-myeloma drug sales
Shares of Legend biotech Corp. LEGN, -1.00% gained 3.7% premarket on Thursday after the company said it...
July 20, 2023, 8:23 am
Vir biotechnology says mid-stage trial of a flu treatment failed to meet main goals
Vir Biotechnology Inc. VIR, +0.92% said Thursday a mid-stage trial of a treatment for symptomatic flu failed to meet its main goals. The Phase 2 trial...
July 20, 2023, 8:10 am
The 3 most undervalued biotech stocks to buy now: july 2023
The biotechnology sector is the reason why treatments and diagnostics for all mankind have experienced exponential advances. If you are passionate abo...
July 20, 2023, 8:08 am
Why is eliem therapeutics (elym) stock up 6% today?
Eliem Therapeutics (NASDAQ: ELYM ) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives....
July 20, 2023, 8:04 am
Eliem therapeutics' stock soars 21% premarket after company says it may sell itself
Eliem Therapeutics Inc.'s stock ELYM, -4.76% soared 21% in premarket trade Thursday, after the biotech, which specializes in therapies for neuronal ex...
July 20, 2023, 6:57 am
Why shares of immunitybio were up on wednesday
ImmunityBio is a clinical-stage biotech company. The company's lead therapy candidate is Anktiva....
July 19, 2023, 12:57 pm
biotech and biopharma executive eliana clark joins culture biosciences’ advisory board
The recently established group of senior industry leaders provides guidance as the company executes its growth strategy SAN FRANCISCO, July 19, 2023 (...
July 19, 2023, 10:39 am
Acumen soars on alzheimer's study
Two years removed from an IPO, Acumen Pharmaceuticals, Inc. NASDAQ: ABOS looks like it made a good decision to go public. Shares of the Charlottesvill...
July 19, 2023, 9:59 am
Should you invest in the ishares biotechnology etf (ibb)?
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the He...
July 19, 2023, 7:37 am